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Using a newly developed near-infrared (NIR) dye that fluoresces at two different wavelengths (dichromic
fluorescence, DCF), we discovered a new fluorescent substrate for Akt, also known as protein kinase B, and a
method to quantitatively report this enzyme’s activity in real time. Upon insulin activation of cellular Akt,
the enzyme multi-phosphorylated a single serine residue of a diserine DCF substrate in a time-dependent
manner, culminating in monophospho- to triphospho-serine products. The NIR DCF probe was highly
selective for the Akt1 isoform, which was demonstrated using Akt1 knockout cells derived from
MMTV-ErbB2 transgenic mice. The DCF mechanism provides unparalleled potential to assess the
stimulation, sustainability, and reversibility of Akt activation longitudinally. Importantly, NIR fluorescence
provides a pathway to translate findings from cells to living organisms, a condition that could eventually
facilitate the use of these probes in humans.

P

rotein kinases regulate diverse cellular processes, including biochemical reactions and molecular interactions. The overexpression of kinases is also associated with a host of diseases, such as cancer, cardiovascular
diseases, diabetes, and inflammation1, raising interest in the use of their signaling pathways as important
drug targets2,3. Protein kinase B, also known as Akt, has a particularly interesting signaling pathway because it is
the central hub for some pathophysiological processes4. Recent studies have shown that Akt exists in three
isoforms with high structural homology: Akt1, Akt2, and Akt3. However, each isoform has been shown to play
distinct, and sometimes contradictory, roles in normal biological and pathological events5.
These interesting findings have driven the establishment of in vitro assays to determine the functional status
and expression levels of Akt isoforms in cells and tissues. Although many endogenous Akt substrates are known,
most share tertiary structure and amino acid sequence homology (i.e., they are non-isoform specific)6. Therefore,
researchers rely on isoform-specific antibodies to decipher the roles of each kinase subtype. Determining Akt
activity is traditionally accomplished by western blotting and ELISA, which are used to detect phosphorylation at
Thr308 and Ser473. Unfortunately, these techniques require multiple steps to determine whether a single phosphorylation event has occurred7.
In addition to the challenges of generating reproducible antibodies with low cross-reactivity, the cell lysis or
fixed cell approach used with these antibodies lacks the ability to capture the dynamics and multidirectional cell
signaling pathways that occur in cellular environments7. In principle, cell assays could overcome the above
limitations, but the widely used methods typically require the encoding of FRET-based fluorescent or bioluminescent proteins that may confine their use to preclinical studies. Moreover, the FRET technique has several
problems: the need for optimal distance (typically 1–10 nm) and spectral overlap between donor and acceptor
chromophores, the use of two or more fluorescent proteins that could alter the inherent biological properties of
the enzyme, and the existence of autofluorescence caused by excitation of proteins in the visible wavelengths8,9.
Although fluorescent organic dyes are widely used for biological imaging, the current assays with these molecular
probes do not combine the diverse desirable characteristics of a protein kinase assay. In addition, the development
of Akt isoform-specific small molecular probes is challenging. These challenges attest to the need for a versatile,
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Akt-specific molecular probe with high sensitivity, high-throughput,
and real-time reporting capabilities in live cells and potentially in
living organisms.
Recently, we discovered that certain near-infrared (NIR) dyes
derived from cypate emit fluorescence at two different wavelengths
(approximately 700 nm and 800 nm) along with two corresponding
distinct fluorescence lifetimes10. Although the mechanism of the dual
(dichromic) fluorescence is not fully understood at this time, we
found that the induction of structural asymmetry in some carbocyanine molecules amplifies the dichromic fluorescence (DCF)
phenomenon. On this basis, we postulated that structural transformation of the NIR cyanine dyes from symmetrical to less symmetrical molecules, or vice versa, could alter the relative intensities of
the DCF, thereby providing a unique contrast mechanism to quantitatively detect, image, or monitor the activities of biomolecules in
cells and tissues. In this study, the biological relevance of this concept
was demonstrated by using Akt to induce and modulate the DCF.
This study also identified a molecular probe that is highly specific for
the Akt1 isoform.

Results
Phosphorylation of certain NIR fluorescent dyes induces dual NIR
fluorescence. Kinases, such as serine/threonine kinases, are ideal for
exploring the DCF mechanism because phosphorylation of their
substrates can induce significant structural asymmetry that favors
DCF. Therefore, we first prepared a series of compounds that exhibit
DCF based on the structural template of a bifunctional NIR
fluorescent dye molecule, cypate11, and serine, which possesses a
hydroxyl group for phosphorylation (Figure 1a). The reaction of
serine with cypate resulted in the compound cypate-diserine
(LS456). We then prepared a control cypate derivative, LS542,
which has the same structural features as LS456, but each of the
hydroxyl groups of the serine residues was blocked with tert-butyl
to prevent subsequent phosphorylation. We also prepared and
evaluated the DCF properties of cypate-monophosphoserine
(LS455) and cypate-diphosphoserine (LS631), which mimic the
mono- and di-phosphorylation products of LS456 (Figure 1a). All
of the products were purified with a semi-preparative HPLC system
and characterized by analytical HPLC, a high-resolution mass
spectrometer, and spectroscopic methods (see Supplementary
Methods).
Spectral analysis of LS542, LS455, LS456, and LS631 were conducted in methanol (Figure 1b). Their optical properties, including
the quantum yield, absorption coefficient, and photostability, are
summarized in Table 1 and Supplementary Figure 1. LS542,
LS456, and LS631, which have more structural symmetry than
LS455, exhibit major and smaller emission peaks at approximately
810 nm and 710 nm, respectively [These peaks are denoted as
700 nm (or green) and 800 nm (or red) emissions throughout this
paper]. Conversely, the nonsymmetrical LS455 shows a weak emission at 800 nm, but strong fluorescence at 700 nm, which is a
reversal of the observed spectral profile for the compounds. A variety
of factors may contribute to this observation, including the formation of aggregates, reduction in iminium charge delocalization along
the polymethine chain, dimerization, or the existence of two interconvertible molecules at equilibrium in the ground state. The exact
mechanism of the observed DCF is under further investigation.
However, empirical evidence strongly suggests that the transformation of LS456 to LS455 significantly enhances the 700 nm emission,
which will be useful for reporting the functional status of the target
enzyme. A first step toward accomplishing this transformation in a
biological setting is to identify a kinase that can utilize LS456 as a
substrate.
Akt phosphorylates LS456 in vitro. LS456 was used as a model
compound because its two serine residues are highly amenable to
SCIENTIFIC REPORTS | 3 : 1697 | DOI: 10.1038/srep01697

phosphorylation. We first investigated the stability of the 700 nm
and 800 nm emissions of LS456 and its synthetic phosphorylation
product, LS455, in tris saline buffer at 30uC in buffers for 240 min
under different conditions. Although some fluctuations were noted
in the spectral profile of LS455 at the early time points, the ratios of
the 700/800 nm emissions for LS455 and 456 were stable over time
(Supplementary Figure 1), indicating that subsequent fluorescence
ratiometric changes at these wavelengths could be attributed to a
target biological event.
We next assessed the selective phosphorylation of the putative
fluorescent substrate, LS456, by a subfamily of serine/threonine
kinases: PKA, Akt, and PKC in the presence of ATP (a phosphate
source). Phosphorylation of LS456 was monitored in the 700-nm
channel, where fluorescence intensity enhancement was expected.
We found that treatment of LS456 with Akt resulted in a significant
fluorescence increase at 700 nm (Figure 2a), whereas the rate of
fluorescence change remained practically unaltered for PKA and
even decreased for PKC (Supplementary Figure 2). This result suggests that LS456 was transformed by Akt. However, we found that
red fluorescence generally decreased for all the enzymes, albeit in a
kinase-specific manner. Because LS456 exhibited the anticipated
spectral response to phosphorylation, we further assessed its behavior in the presence of the other serine/threonine kinases, p70S6K
and RSK1, as well as a tyrosine protein kinase (PI3K), to establish
specificity of the observed 700-nm fluorescence enhancement under
similar conditions as Akt. As with the PKA and PKC results, there
was no significant increase in the 700-nm emission with any of these
other kinases. A significant decrease was even observed for p70S6K at
the 700 nm emission, with a small increase in the 800-nm channel
(Supplementary Figure 3). Deciphering the consequence of this
unique spectral shift in the presence of p70S6K is not the focus of
the current study. Nevertheless, when taken together, the above in
vitro results demonstrate that Akt enhances the DCF change of
LS456 by increasing the 700-nm emission, which strongly suggests
the occurrence of structural transformation of the molecular probe
through phosphorylation. The specificity of the LS456-Akt molecular recognition was further confirmed by the lack of a 700-nm fluorescence increase when other serine/threonine kinases (PKA, PKC,
p70S6K and RSK1) or tyrosine kinase (PI3K) were used under similar conditions as in the Akt assays.
Replacement of LS456 with the negative control compound,
LS542, in the above assays resulted in a significant fluorescence
decrease in both the 700-nm and 800-nm channels in the presence
of PKA, Akt, and PKC (Figure 2a and Supplementary Figure 2
bottom panel). The hydroxyl group of serine in LS542 is blocked
with a tert-butyl group to prevent phosphorylation. Therefore, the
correlated trend in fluorescence decrease in both channels could be
attributed to the spontaneous aggregation of the highly hydrophobic
LS542 in aqueous medium, which is different from the DCF effect
observed with LS456.
Cell lysates demonstrate Akt phosphorylation of LS456. After
demonstrating the preferential phosphorylation of LS456 by Akt
relative to other kinases, we used the DCF approach to monitor
Akt activity in cell lysates. Previous studies have shown that the
binding of insulin to its cell surface receptor stimulates phosphoinositide-3 kinase (PI3K), which then produces the lipid second
messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3)2. PIP3, in
turn, activates Akt and downstream effectors12,13. The breast cancer
cell line MCF-7 is widely used to assess Akt activation by insulin. In
this study, MCF-7 cells were first transfected with either LS456 or
LS542 using GeneJuice transfection reagent and were then incubated
with 150 nM insulin to activate Akt14. The cells were homogenized,
and the supernatant was placed in a tube and imaged in both the 700nm (Ex/Em 633 nm/670–730 nm, green color) and 800-nm (Ex/Em
785 nm/805–830 nm, red color) channels. We used two different
2
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Figure 1 | Structures and spectra of molecular reporter probe and controls. (A) Synthesis of LS456, LS455, LS542, and LS631. Reagents and conditions:
(a) 3-Bromopropionic acid in dichlorobenzene, 120uC; (b) DIC (N,N’-diisopropylcarbodiimide) and HOBT (hydroxybenzotriazole) in DMF
(dimethylformamide) and H-Ser(tBu)-OtBu.HCl; (c) Fmoc-Ser[PO(OBzl)OH]OH was loaded onto Br-Wang resin with cesium iodide and DIEA (N,Ndiisopropylethylamine); (d) DIC and HOBT in DMF; (e) 95% TFA/5% H2O; (f) N-(5-anilino-2,4-pentadienylidene)aniline hydrochloride, acetic
anhydride, DCM, MeOH, and sodium acetate (see the Methods section for details). LS455 is a model of LS456 after phosphorylation. The control LS542
probe has the hydroxyl phosphorylation site of serine blocked with tert-butyl group. (B) Absorption (left) and emission (right) spectra of LS456, LS455,
LS542 and LS631 in methanol. Absorbance units were kept below 0.2 for fluorescence measurements. The fluorescence spectrum of LS455 demonstrates
the expected spectral shift when a kinase phosphorylates LS456. CPS, photon counts per second.
SCIENTIFIC REPORTS | 3 : 1697 | DOI: 10.1038/srep01697
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Table 1 | Spectral properties of LS455, LS456, LS542, and LS631 in methanol
Compounds
Optical Properties
Absorption Coefficient at 780 nm (cm21M21)
Absorption Coefficient at 620 nm (cm21M21)
Quantum yield at 800 nm emission (ex. @620 nm)
Quantum yield at 700 nm emission (ex. @620 nm)
Relative brightness* at 800 nm emission (ex. @620 nm)
Relative brightness at 700 nm feature (ex. @620 nm)

LS456

LS455

LS542

LS631

215000
11893
8.5%
1.7%
1
0.20

209300
13799
2.4%
6.8%
0.33
0.93

218800
13592
8.7%
0.56%
1.17
0.08

217400
12020
9.0%
0.72%
1.07
0.09

*
Relative brightness calculated by multiplying the absorption coefficient of the dyes at 620 nm (common absorption coefficient) by their respective quantum yields of 700 and 800 nm features, and
referenced to LS456 at 800 nm.

lasers to excite the probes sequentially because our confocal
microscope is equipped with a limited number of NIR lasers in the
NIR window (633/785 nm). Although we were able to simultaneously
obtain dual emissions with 620 nm excitation in solution-based
spectroscopy studies, the brightness for the 800 nm emission in
cells was relatively weak at 633 nm excitation. After excitation at
633 nm and 785 nm, the fluorescence image of cell lysates treated
with LS456 clearly showed the transformation of the normally red to
green fluorescence, which is similar to the spectral properties of the
monophosphoserine compound, LS455 (Figure 1b and 2b). In
contrast, with the negative control compound LS542, the red
emission was exclusively observed, indicating the absence of a
structural transformation of the compound.
To correlate the DCF spectral change with Akt phosphorylation,
we used a co-immunoprecipitation (Co-IP) method with a monoclonal anti-phosphorylated Akt473 antibody to isolate the Akt protein-substrate complex, followed by double MS treatment of the
residue (MS/MS analysis). We found a time-dependent phosphorylation of LS456. The monophosphorylated derivative of LS456
(M/M 1 H 879.2 Da) was the major product after 20 min of insulin
activation, which is the same as LS455. Although previous reports
demonstrated that Akt typically phosphorylates one serine in the
presence of two or more serine residues15,16, after 20 min, we also
observed significant molecular ions at 957.60/959.60 Da corresponding to the two phosphate groups of LS456. At 45 min of insulin
activation, the peaks for the mono- and di-phosphoserine products
disappeared in favor of a triphosphoserine adduct of LS456
(Supplementary Figure 4b). The significant decrease in the abundance of the diphosphoserine molecular ion peak and subsequent
dominance of the triphosphoserine ion after 45 min of insulin
activation suggests that this product was derived from the diphosphoserine derivative. If phosphorylation occurred at each of the
serine residues of LS456, the diphospho-diserine should have a similar structure as LS631 (Figure 1a). Based on the DCF mechanism,
such symmetrical structure would regenerate a red signal as the
molecules convert from the green monophosphoserine LS455 to
LS631. Instead, the rate of the green fluorescence change increased
over time, while that of the red emission decreased correspondingly
(Supplementary Figure 2b).
The enhancement of the 700-nm fluorescence most likely suggests
that the second phosphorylation occurred at the monophosphoserine residue to form a pyrophosphoserine derivative. Similarly, the
combined reduction in the pyrophosphate molecular ion abundance
and the further enhancement of the green fluorescence at time points
of long insulin activation strongly suggests that the predominant
triphosphate group was added to the same serine residue.
Otherwise, phosphorylation of the second serine would decrease
the 700-nm emission while increasing the 800-nm emission, which
was not observed. This is the first evidence of the ability of Akt kinase
to triphosphorylate its substrate.
To further explore the optical properties of the phosphoserine
derivatives, we evaluated LS455 and LS631 in the presence of the
SCIENTIFIC REPORTS | 3 : 1697 | DOI: 10.1038/srep01697

serine/threonine kinases PKA, Akt, and PKC under similar conditions as described for LS456 above. While all of the assays showed
fairly constant or a significant decrease in the fluorescence signal for
both compounds with all the enzymes, only Akt generated a 3-fold
fluorescence increase of the 700-nm emission, with a concomitant
decrease in the 800-nm channel when LS455 was used
(Supplementary Figure 5). Because there was a large DCF change
for LS455 in MCF-7 cells under similar conditions as LS456, the
lysate was further evaluated by MS/MS and spectroscopic analyses
after co-IP. In addition to the starting LS455 and the hydrolysis
product (LS456), the data show that additional phosphorylation of
LS455 occurred. In particular, spectroscopic and MS/MS analysis of
the isolated products bound to Akt1473 showed that one and two
phosphate groups were present (Supplementary Figure 5 top panel
and Supplementary Figure 6). These data further suggest that LS455
was pyrophosphorylated (two phosphate groups on the same serine
residue) by Akt, as seen by the additional enhancement of the 700nm emission. This result highlights a potentially new role for Akt,
which is not known to pyrophosphorylate its substrates. Under similar conditions as LS456 and LS455, Akt did not structurally transform LS631 (Supplementary Figure 5 bottom panel), unless it
rapidly formed di-pyrophosphate, which would retain the original
spectral profiles of the two emissions.
LS456 reports Akt activation in living cells in real time. Encouraged
by the above findings, we then explored the potential of using the
DCF contrast technique to image insulin-mediated activation of Akt
in living cells. To accomplish this goal, MCF-7 cells were incubated
with LS542, LS456, LS455, and LS631 in the presence of 150 nM
insulin. The cells were imaged using NIR fluorescence confocal
microscopy. The 800-nm fluorescence persisted in LS542 treated
cells throughout the experimental period (Figure 2d), but decreased
significantly between 0.5 h and 1 h. Subsequent removal and replacement of insulin with insulin-free culture medium reestablished the
red fluorescence intensity to the initial level.
Whereas the 800-nm fluorescence persisted in cells treated with
LS542, rapid transformation from 800-nm to 700-nm fluorescence
was observed in the cells incubated with LS456 (Figure 2c).
Subsequent removal of insulin from the medium by washing the cells
and adding insulin-free culture medium reestablished the red fluorescence, indicating the reversibility of the phosphorylation. The reintroduction of insulin in the LS456 culture medium reinitiated the
process of red-to-green transformation of the spectral features of the
probe. Up to 4 cycles of this transformation were observed when
insulin was removed within 20 min of incubation, and the cells were
allowed to incubate in insulin-free medium for 1 h during each cycle.
The insulin-induced DCF cycles in this study were limited by the
number of cells remaining after each wash cycle (many cells were lost
with each wash). These results suggest that LS456 was phosphorylated in the process and that Akt remains in the active state as long as
insulin is present in the culture medium. Thus, the reversibility and
4
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Figure 2 | Selective phosphorylation of LS456 over LS542 by insulin-activated Akt in MCF-7 cells. (a) In vitro enzyme assay demonstrating the rate of
fluorescence increase in the 700-nm channel (green) for LS456, suggesting mono-phosphorylation of the probe. The control compound LS542 had
negligible fluorescence changes in both the 700-nm and 800-nm (red, shown) channels. (b) Cell lysate of LS456 and LS542 using monoclonal
anti-phosphorylated Akt473 in MCF7 cells after insulin treatment for 20 min. Excitation at 650 and 785 nm and imaging in both the 700-nm and 800-nm
channels show that only LS456 transformed from 800-nm (red) to 700-nm (green) emission, indicating that Akt phosphorylated LS456 but not LS542.
(c–f) Real-time NIR fluorescence confocal microscopy of the molecular probe and control compound. The time-dependent transition of LS456 from red
to green suggests rapid phosphorylation of the enzyme substrate. The replacement of the insulin solution with non-insulin culture medium demonstrates
the reversibility of the process (c). This spectral transition was successfully inhibited with the PI3K inhibitor, wortmannin, in the presence of insulin (d).
Similar experiments with LS542 with insulin stimulation (e) and in the presence of wortmannin (f) did not generate any increase in the 700-nm channel.
All microscopy studies were conducted at 30uC. (g–i) Quantitative analysis of the images of panel (c–f). The fluorescence of LS456 at the 700 emission
channel increased 10-fold at 50 min after insulin administration (g). The 700/800-nm fluorescence enhancement ratio of LS456 by insulin stimulation of
Akt was . 150-fold at 50 min post-treatment (h), which was blocked with the PI3K inhibitor wortmannin (i). Red colors represents Ex/Em 5
785 nm/805–830 nm. Green colors represents Ex/Em 5 633 nm/670–730 nm. Fluorescence images in cells are superimposed on differential interference
contrast images. Error bars are reported as mean 6 standard deviation (N 5 8).
SCIENTIFIC REPORTS | 3 : 1697 | DOI: 10.1038/srep01697
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Figure 3 | Insulin does not activate the fluorescence enhancement for LS456 at 700 nm in Akt1-deficient mammary tumor cells. (a) The fluorescence
intensity (FI) of LS456 in mammary epithelial cells decreased in the 800-nm channel and increased in the 700 nm channel, which did not occur in
Akt1-deficient cells. (b, c) Quantitative analysis of the FI in WT and Akt1-deficient cells. Fluorescence images in cells are superimposed on differential
interference contrast images All figures are at the same scale bars: 20 mm; error bars are reported as mean 6 standard deviation (N 5 8).

longitudinal activation of Akt by new drug inhibitors can be studied
by the DCF contrast technique.
Direct quantitative analysis of the DCF intensity changes over
time was achieved by acquiring and displaying all of the confocal
images on the same intensity scale (Figure 2g–i). In agreement with
the DCF contrast mechanism, there was no fluorescence increase and
minimal fluorescence intensity change for the control LS542 in the
700-nm channel (Figure 2g).
In the 800-nm emission channel, the fluorescence signal for both
LS456 and LS542 decreased gradually over time, but the rate of signal
decrease in cells treated with LS456 was much faster than that
of LS542 (Supplementary Figure 7). Thirty minutes after the
addition of insulin, the fluorescence intensity of LS456 in the 800nm emission channel decreased 10-fold, whereas that of LS542
decreased 2.5-fold. In all cases, only phosphorylation of LS456
induced a significant fluorescence increase in cells in the 700-nm
channel.
LS456 reports the inhibition of Akt phosphorylation potential in
cells. To verify that the spectral change was induced by kinasemediated phosphorylation of LS456, we first used a universal
kinase inhibitor, K252a, to inhibit LS456 transformation to LS455,
as manifested by a 800-nm to 700-nm emission shift. We found that
the phosphorylation of LS456 was completely inhibited (not shown).
In contrast, the inhibitor did not have a measurable effect on the
fluorescence of the control LS542 probe. To further assess the
downstream inhibition of Akt, we used wortmannin, a direct
inhibitor of PI3K, which is an upstream activator of Akt17. In our
in vitro screening assay, we showed that PI3K does not phosphorylate
LS456 (Supplementary Figure 3c, Supplementary Figure 3f).
Treatment of the MCF-7 cells with wortmannin and either LS456
or LS542, followed by co-incubation with insulin as described above,
SCIENTIFIC REPORTS | 3 : 1697 | DOI: 10.1038/srep01697

did not produce significant fluorescence changes in either the
700-nm or 800-nm emission channel (Figure 2e, 2f, 2i). This
demonstrates that wortmannin inhibits insulin activation of Akt in
MCF-7 cells. Direct evidence of the specificity of Akt phosphorylation of LS456 was obtained by treating MCF-7 cells with an
Akt-specific inhibitor, perifosine. This treatment resulted in the
inhibition of LS456 phosphorylation, as evidenced by the lack of
the 700-nm fluorescence increase (Supplementary Figure 8a).
LS456 specifically reports the activity of the Akt1 isoform in cells.
MCF-7 cells express all three isoforms of Akt with distinct subcellular
locations18. Previous studies have shown that Akt1, Akt2, and Akt3
are localized in the cytosol, mitochondria, and nuclei of breast cancer
cells, respectively. On the basis of the predominant cytoplasmic
distribution of LS456 in MCF-7 cells, it is logical to anticipate that
Akt1 is actively involved in the phosphorylation of LS456. We
therefore employed carefully characterized primary mammary
epithelial tumor cells derived from MMTV-ErbB2 transgenic mice
in either the wild type (Akt1/1) or Akt1 knockout (Akt1-/-)
background19 to determine the role of Akt1 in LS456 phosphorylation. The results show that insulin stimulated Akt activity
in the Akt11/1 cells, as demonstrated by the transformation of the
red to green emission of LS456 (Figure 3). In contrast, LS456 did not
respond to insulin treatment in the Akt1-/- cells, which also express
the Akt2 and Akt3 isoforms of the enzyme. Therefore, the large DCF
change observed in different cells can be attributed to Akt1.
Considering the important role Akt1 plays in pathophysiology and
the overarching need to develop small molecule reporters of this
isoform, the discovery of LS456 as an Akt1 substrate and selective
reporter of its functional status will facilitate the real-time assessment
of Akt1 activation in living cells, with the potential to delineate its
functions from those of other isoforms in vivo.
6
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Discussion
Currently, inefficient, discrete, and low signal-to-noise imaging
methods are used to monitor the change in Akt activity in response
to insulin stimulation8,9,20. Consequently, a new approach, such as the
DCF contrast technique, could provide a viable alternative method.
The dramatic induction of the DCF change of LS456 by Akt suggests
that the compound is a substrate for this enzyme. The consensus
substrate motif for Akt has the general peptide sequence Arg-Arg-XX-Ser/Thr-Q (Q represents a hydrophobic amino acid), which binds
to the catalytic domain of the enzyme through hydrophobic and/or
ionic interactions21. Although the new substrate lacks the two arginine residues that generally determine the specificity of Akt and the
phospho-Ser/Thr binding domain22, other studies have shown that
the binding between phosphorylated Akt and its substrate could
significantly depend on hydrophobic amino acid residues23, which
is consistent with the general structure of LS456. Particularly,
the presence of an elongated and a flexible heptamethine hydrophobic chromophore core of cypate, a positively charged intrinsic
iminium ion, and serine residues for phosphorylation most likely
allowed LS456 to serve as both a substrate and a reporter for Akt
activity.
The exceptionally high detection sensitivity of the 700-nm emission is supported by the spectral properties of the different products,
including the relative brightness of the two species contributing to
the DCF (Table 1). The relative brightness of LS456 at 700 nm
changed from 20% to 93% upon phosphorylation (LS455), accompanied by a significant decrease from 100% to 33% in the relative
brightness of the 800-nm emission of LS456. Thus, the large change
in the spectral properties of the molecular probes demonstrates that
DCF is a highly sensitive method for cellular imaging of Akt activity
in living cells.
Although interpretation of the DCF for Akt is straightforward,
changes in the 700/800 nm emission ratios were different for other
proteins, thereby providing an insight into a potential approach to
analyze DCF data. The regeneration of the red fluorescence in cells
after a significant decrease following the removal of insulin and cell
washing suggests that the fluorescence change in the 800-nm channel
can be attributed to specific interactions between the molecular
probe and the kinase. This interpretation only stands when the
accompanying changes in the 700-nm emission is incorporated in
the analysis. For example, the 700/800 nm vs. time fluorescence ratio
is approximately 160 after 50 min for LS456, compared to the ratiometric change for LS542, which is only approximately 3 (Figure 2h).
This sharp ratio increase relative to the moderate change anticipated
from the solution spectra of LS456 and LS455 (Figure 1b) is due to
the reduction in the 800-nm emission in cells, most likely caused by
the binding of these compounds to Akt.
We also postulate that a biological phenomenon that simultaneously increases or decreases the 700/800-nm fluorescence does
not reflect a structural transformation of the probe and should not
be considered a DCF response. For structures similar to LS456, we
can further postulate that mono-, di-, or tri-phosphorylation of the
same serine residue is expected to enhance the 700-nm emission, but
monophosphorylation of each serine residue to generate a symmetrical diphosphoserine should reverse this effect in a time-dependent
DCF change. Furthermore, a decrease in 800-nm fluorescence with
corresponding stable 700-nm fluorescence intensity could be attributed to LS456 interactions with biomolecules. Thus, monitoring the
changes in the 800-nm emission could be useful for reporting the
extent of molecular interactions in cells. Irrespective of the causative
factors that perturb the 800-nm readout, the Akt-mediated phosphorylation of LS456 results in a significant fluorescence emission
shift from 800-nm to 700-nm emissions.
Although a variety of methods is available for ratiometric analysis
of data emanating from spectrally distinct emissions, we opted to use
a simple ratio of the 700/800 nm relative fluorescence intensity. This
SCIENTIFIC REPORTS | 3 : 1697 | DOI: 10.1038/srep01697

approach is particularly suitable for our study because an increase in
the 700 nm emission over a correspondingly small decrease in the
800 nm channel significantly enhances the contrast. A potential
problem with this unconstrained method is the possibility of obtaining disproportionately large ratios if the 800 nm intensity
approaches zero. In this case, an alternative method is to ratio the
difference in intensity of the two emissions, followed by dividing the
sum of the emissions to constrain the ratiometric change between 1
and 21. This calculation translates to a ratiometric change of 0.936
and 0.988 at 10 min and 50 min, respectively, for LS456 (Figure 2
and Supplementary Figure 7). These changes correspond to 30- and
160- fold increase in the 700/800 nm fluorescence ratio using the
simple fluorescence intensity ratiometric approach.
We were intrigued by the possibility that Akt could multiply phosphorylate a single serine residue of LS456, as illustrated in Figure 4.
For example, pyrophosphorylation was preferred over the phosphorylation of two individual serine residues (Supplementary Figure 5
and Supplementary Figure 6). Based on the DCF concept, diphosphorylation to give LS631 would revert the 700/800-nm emission of
LS455 in cells. Time-lapse cell microscopy with the diphosphoserine
LS631 in MCF-7 cells has a similar imaging profile as LS542, suggesting that this compound was not perturbed in vivo or underwent
spontaneous pyrophosphorylation on each monophosphoserine
(Supplementary Figure 8c). In contrast, LS455 showed an initial
co-existence of both red and green fluorescence within 2 min postincubation (Supplementary Figure 8b). After 2 mins, the 700-nm
fluorescence increased significantly, reaching a plateau at approximately 20 min. The higher 700-nm fluorescence remained intact
throughout the duration of the study. This trend was quantitatively
confirmed as specific to Akt relative to other kinases (Supplementary
Figure 5). The 700-nm fluorescence saturation for LS455 (20 min)
was much faster than that of LS456 (at 40 min) under similar conditions. Unlike LS456, which was dephosphorylated within 60 min
after removing insulin from the culture medium, the dephosphorylation of LS455 was not complete until 270 min post-removal of
insulin.
Recent studies support the potential of Akt to multiply phosphorylate the same serine residue19,24,25. These studies showed that the
binding of ATP to Akt induced an intramolecular interaction
between the phosphorylation sites and other domains in the protein,
creating a cage around the phosphate group and restricting access of
phosphatases to these sites. This interaction favors the pyrophosphorylation and triphosphorylation of small molecules, such as
LS456, from the initial monophosphoserine site25. Removal of insulin
could lead to subsequent uncaging of the binding pocket, which
permits the dephosphorylation and inactivation of the kinase.
Another report demonstrated the posttranslational phosphorylation of the monophosphoserine by inositol pyrophosphate kinases26.
However, we do not believe that these kinases mediated LS456 pyroand tri-phosphorylation because these multiple phosphorylations
were also observed in vitro with only Akt. Thus, the DCF probes
may provide a new contrast mechanism to distinguish diphosphorylation on two different serine residues from posttranslational pyroor tri-phosphoserine products. These results appear to uncover the
potential involvement of Akt in the multi-phosphorylation of its
substrates. The next logical step is to assess the native Akt substrates
for the presence of pyro- or tri-phosphates.
In this study, the real-time DCF method revealed the reversibility
and sustainability of insulin stimulation of Akt. Thus, the dynamic
profile of the DCF change with the different compounds studied can
be used to uncover intricate molecular events that would otherwise
be difficult to observe by current methods. It is also possible to use
this approach to discover other substrates for kinases by preparing
different Ser/Thr peptides on the dye structural framework that
enables the reporting of the functional status of diverse enzymes.
To optimize the molecular design, it would be valuable to explore
7
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Figure 4 | Illustration of the multiple phosphorylation of LS456 by Akt. The data suggest addition of multiple phosphate groups to one residue of the
diserine molecular probe, LS456. After insulin binding to its cell membrane receptors, PI3K was activated to phosphorylate PIP2 into PIP3, which then
binds Akt. mTOR complex 2 phosphorylates Akt on the hydrophobic motif 473Ser, and the activated Akt phosphorylates LS456 stepwise to form the
mono-, pyro-, and tri-phosphoserine sequentially. (a) Insulin-mediated phosphorylation of LS456. (b) De-phosphorylation of mono- and multiplyphosphorylated LS456 after insulin removal. Phosphatidylinositol 3-kinase (PI3K), phosphatidylinositol-3,4,5-trisphosphate (PIP3), mTOR complex 2
(mTOR C2).

the limits of the DCF mechanism by replacing serine with peptide
substrates for different kinases.
Although we did not investigate the subcellular localization of the
probes, the cytoplasmic distribution of LS456 in MCF-7 cells showed
punctate fluorescence (Figure 2c) compared to LS542, which exhibited a more diffuse fluorescence (Figure 2e). The images suggest that
the hydrophobic LS542 is primarily localized in the cytosol, while the
more hydrophilic LS456 and its phosphorylated derivatives appear to
be associated with the outer membranes of intracellular organelles.
Therefore, the unique intracellular distribution of different Akt in
three distinct intracellular compartments may be responsible for the
selective phosphorylation LS456 by Akt1. Unlike the cytosolic Akt1
which has access to LS456 in the cytoplasm, the other two isoforms
Akt2 and Akt3 are localized in the mitochondria and the nuclei of
breast cancer cells, respectively. Because LS456 does not appear to
internalize in these organelles, it is likely that the observed selective
phosphorylation is mediated by intracellular physical boundaries.
Future studies will explore the downstream effect of Akt phosphorylation of LS456 and its potential to serve as an inhibitor of the
oncogenic signaling pathway of Akt. To increase the imaging speed,
minimize potential photobleaching, and overcome any artifact from
fluctuations in the laser power, efforts are in progress to identify the
optimal excitation laser for both emissions in cells. Finally, an
important advantage of the NIR fluorescence imaging is the low
autofluorescence in this spectral region, which improved the detection sensitivity of the DCF method. Coupled with the deep penetration of NIR light in tissue, the NIR fluorescence provides a pathway
to translate findings from cells to living organisms, a condition that
will ultimately facilitate the use of these probes in humans. This
SCIENTIFIC REPORTS | 3 : 1697 | DOI: 10.1038/srep01697

method will be of use in examining patients with cancer, diabetes
and other disease because of the association of Akt signaling pathways with these conditions27,28.

Methods
Reagents. O-tert-butyl-L-serine-tert-butyl ester hydrochloride, 2-(1H -benzotriazol1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), 1hydroxybenzotriazole hydrate (HOBt), O-(7-azabenzotriazol-1-yl)-N,N,N’,N’tetramethyluronium hexafluorophosphate (HATU) and brominated Wang resin
were obtained from Nova Biochem (San Diego, CA). N-a-Fmoc-O-benzyl-Lphosphoserine was purchased from AnaSpec Inc. (San Jose, CA). Trifluoroacetic acid
(TFA), N,N’-diisopropylcarbodiimide (DIC), N-(5-anilino-2,4-pentadienylidene)
aniline hydrochloride, 1,1,2-trimethyl-1H-benz[e]indole, 3-bromopropionic acid,
cesium iodide (CsI), N,N-diisopropylethylamine (DIEA), dichloromethane (DCM),
N,N-dimethylformamide (DMF), ethanol, acetonitrile, hexane, ethyl acetate and
dichlorobenzene were purchased from Sigma-Aldrich (St. Louis, MO).
Spectroscopy studies. The absorption and fluorescence spectra of the compounds in
methanol were recorded on a Beckman Coulter DU 640 UV-visible
spectrophotometer (Beckman Coulter, Inc., Indianapolis, IN) and a Fluorolog-3
spectrofluorometer (Horiba Jobin Yvon, Inc., Edison, NJ), respectively. To capture
the dual fluorescence using spectroscopy, the samples were excited at 620 nm and
emission was captured from 635 nm to 900 nm. The absorption coefficients were
calculated from the standard curves at both 780 nm and 620 nm. The fluorescence
quantum yield was measured at 620 nm excitation, with slit widths set at 5 nm for
both excitation and emission. We calculated the quantum yield by integrating the
emission over a range from 650 nm to 750 nm for the 700 nm emission, and from
750 nm to 850 nm for the 800 nm emission at 620 nm excitation (Table 1). Signal
integration was accomplished with FluorEssence software (Horiba Jobin Yvon).
Indocyanine Green (ICG) and chlorophyll A were used as reference standards for the
800 nm and 700 nm emission, respectively. All measurements were conducted at
room temperature. The stability of LS455 and LS456 was evaluated in Tris-saline
buffer (TBS, 50 mM Tris; 150 mM NaCl; pH 5 7.4) and 150 nM insulin in TBS for
4 h at 30uC using the Fluorolog-3 spectrofluorometer.
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Live cell Akt activity monitoring. MCF-7 cells (ATCC Manassas, VA) were
maintained at 37uC and 5% CO2 in DMEM medium supplemented with 10% fetal
bovine serum, 100 unit/mL penicillin, and 100 mg/mL streptomycin. The cells (1 3
104 cell/well) were cultured in glass bottom dishes (MatTek Co., Ashland, MA 01721)
overnight and transfected with 5 mM of each LS456, LS455, LS542 using GeneJuice
transfection reagent (Novagen, Madison, WI) in the dish for 18 h at 37uC, according
to the manufacturer’s instructions. The transfected cells were treated with 150 nM
insulin in Tris-buffered saline and imaged at 30uC using an FV1000 confocal
microscope with UPLanApo/IR 60X/1.20W objective lens (Olympus, Center Valley,
PA). After washing 3 times for 5 min in TBS, the cells were pretreated for 1 h with
1 mM wortmannin PI3K inhibitor (Cell signaling Technology, Inc., Boston, MA) or
for 2 h with 50 mM Akt inhibitor perifosine (Selleckchem, Inc., Houston, TX). The
treated cells were incubated with 150 nM of insulin and 10 mM wortmannin or
50 mM perifosine in TBS, respectively. Imaging was conducted at different time
points. The mean fluorescence intensity (n 5 8) (Ex/Em 5 633/6702730 nm; Ex/Em
5 785/805–830 nm) in the dishes was determined with FV1000 software. All of the
fluorescence intensity changes at each time point were normalized to the positive
control (0 min). The image of the tubes containing LS456 and LS542 (Figure 2b) were
acquired with LI-COR Pearl Imager (Lincoln, NE) at Ex/Em of 685/705 nm and
785/810 nm channels. Live cell imaging studies were conducted at 30uC, which is the
default room temperature for the imaging platform of our microscope. All images
within the same time series were recorded from the same area of the slides. However,
the live cells moved during the imaging sessions, resulting in variability in the total
number of cells displayed in Figure 2c–f. To account for these changes in the field of
view, eight representative cells were used to quantify the fluorescence using Olympus
FV1000 software. The data shown in Figure 2g–i were obtained from a duplicate of
4different experiments.
Comparison of Akt activity from WT and Akt1-deficient cells. The Akt12/2 and
wild type (WT) cells used in this study were cultured and transfected as previously
described19. Briefly, mammary tumor epithelial cells derived from MMTV-ErbB2
transgenic mice tumors were cultured in F-12 medium (Sigma, St. Louis, MO) with
EGF (10 ng/mL), hydrocortisone (1 mg/mL), penicillin (100 units/mL),
streptomycin (100 mg/mL), and gentamycin (50 mg/mL) and supplemented with 10%
FBS. EGF was obtained from Sigma. The Akt12/2 and WT cells (1 3 103 cell/well)
were cultured in glass bottom dishes and were transfected and imaged in real-time at
30uC using confocal microscopy at different time points. The mean fluorescence
intensity of the cells (n 5 8) (Ex/Em 5 633/670–730 nm; Ex/Em 5 633/731–
800 nm) in the dishes was determined with the FV1000 software and normalized to FI
at the initiation step (0 min).
In vitro phosphorylation assay. Our probes and the Sox reference peptide
(Invitrogen, Carlsbad, CA) were dissolved in assay buffer (20 mM HEPES, pH 7.0,
10 mM CaCl2, 0.05% Brij-35). Different concentrations of probes were mixed with
100 ng of different enzymes and 1 mM ATP (Sigma, St. Louis, MO) in 50 mL assay
buffer at 30uC. The Sox peptide was also mixed with 100 ng of Akt according to the
manufacturer’s instructions. Fluorescence intensity was measured in real time on a
microplate reader (Synergy HT, BioTek Instruments, Inc., Winooski, VT) at lexcitation
5 620 6 20 nm; lemission 5 700 6 10 nm and lexcitation 5 760 6 30 nm; lemission 5
810 6 20 nm. Initial velocities were determined by fitting the initial linear section of
the curve obtained from plots of fluorescence intensity versus time. These initial
velocities were plotted with respect to the substrate concentration.
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